Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R 89439
2. R-89439
1. 147362-57-0
2. R 89439
3. R-89439
4. Chembl37624
5. 3s1r1lz09h
6. 2-((2-acetyl-5-methylphenyl)amino)-2-(2,6-dichlorophenyl)acetamide
7. 141030-40-2
8. 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide
9. Unii-3s1r1lz09h
10. Loviride [usan:inn:ban]
11. Loveride
12. Alpha-apa
13. .alpha.-apa
14. Starbld0009613
15. Loviride [usan]
16. Loviride (usan/inn)
17. Loviride [inn]
18. Loviride [mart.]
19. Loviride [who-dd]
20. Schembl247781
21. Dtxsid60869958
22. (+-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide
23. Bdbm50030539
24. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-
25. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+-)-
26. Hy-15355
27. Cs-0005982
28. D04786
29. R89439
30. Q6692646
31. 2-(2-acetyl-5-methyl-anilino)-2-(2,6-dichlorophenyl)acetamide
32. (+/-)-2,6-dichloro-.alpha.-[(2-acetyl-5-methylphenyl)amino]benzamide
33. (+/-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide
34. 2-(2-acetyl-5-methyl-phenylamino)-2-(2,6-dichloro-phenyl)-acetamide
35. Benzeneacetamide, .alpha.-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+/-)-
Molecular Weight | 351.2 g/mol |
---|---|
Molecular Formula | C17H16Cl2N2O2 |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 350.0588831 g/mol |
Monoisotopic Mass | 350.0588831 g/mol |
Topological Polar Surface Area | 72.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 436 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
ABOUT THIS PAGE
A Loviride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loviride, including repackagers and relabelers. The FDA regulates Loviride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loviride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Loviride supplier is an individual or a company that provides Loviride active pharmaceutical ingredient (API) or Loviride finished formulations upon request. The Loviride suppliers may include Loviride API manufacturers, exporters, distributors and traders.
click here to find a list of Loviride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Loviride DMF (Drug Master File) is a document detailing the whole manufacturing process of Loviride active pharmaceutical ingredient (API) in detail. Different forms of Loviride DMFs exist exist since differing nations have different regulations, such as Loviride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Loviride DMF submitted to regulatory agencies in the US is known as a USDMF. Loviride USDMF includes data on Loviride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Loviride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Loviride suppliers with USDMF on PharmaCompass.
Loviride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loviride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loviride GMP manufacturer or Loviride GMP API supplier for your needs.
A Loviride CoA (Certificate of Analysis) is a formal document that attests to Loviride's compliance with Loviride specifications and serves as a tool for batch-level quality control.
Loviride CoA mostly includes findings from lab analyses of a specific batch. For each Loviride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loviride may be tested according to a variety of international standards, such as European Pharmacopoeia (Loviride EP), Loviride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loviride USP).
LOOKING FOR A SUPPLIER?